Sodium-glucose linked transporter-2 inhibitor renal outcome modification in type 2 diabetes: evidence from studies in patients with high or low renal risk

Citation
Schernthaner G, Groop PH, Kalra PA, et al. Diabetes Obes Metab 2020;22:1024–34.